Adtech firm Magnite (NASDAQ:MGNI) is suing Google (NASDAQ:GOOG) (NASDAQ:GOOGL) following a judge's ruling earlier this year that the tech giant engaged in anticompetitive practices and maintained a monopoly in the digital advertising space, the company said ...

Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter. A copy of the letter can be downloaded here.  U.S. large-cap growth equities recovered from a sharp sell-off in early April by delivering strong returns in the second quarter. The quarterly performance was driven by muted inflation, strong corporate earnings, and improving sentiment around artificial intelligence (AI) and global trade. The portfolio returned 27.7% in the quarter, out ...

We are just seconds away from retail sales and import uh prices and the futures uh this morning have moderated a little bit there more than that but who knows how much movement we see for the next u couple of trading sessions maybe there'll be some Rick Santelli standing by at the CME uh in Chicago Rick uh you got the numbers please yes we are waiting our August read of course on retail sales this is the advanced look we'll get a more penciled in look in about a week and a half and the numbers hitting the w ...

Mirion Technology Inc (NYSE: MIR ) is positioned to benefit from policies that incentivize nuclear power. The world needs more power than ever, and is projected to grow by more than 20% by 2030. ToHi, my name is Sander Pettersen Heio, I am from Norway. My primary focus is on foreign stocks, particularly within the Nordic market, where I analyze companies across various industries, from stable blue-chip firms to emerging market leaders. In addition to Nordic equities, I write about growth stocks in the U.S. ...

We begin this hour with stocks hitting another all time high as investors eye a Fed rate cut for Quincy. Jp morgan rising markets have recovered to new record highs. If policy rates come back into focus, equity valuations are now elevated and markets will struggle for.Joins us now for more folk. Good morning. Good morning.It's good to see you. Let's just go through where things are at right now. Earnings, good jobs data, not good Is one much more important than the other.Yes, it's always about the earnings. ...

YieldMax Ultra Option Income Strategy ETF (NYSEARCA: ULTY ) has been among the favorite of the covered call/high-yielding ETFs that have gained popularity since their inception in early 2024.I am a former investment advisor and owner of several businesses. These days I invest only for myself while continuing to write on a variety of financial and economic topics.Analyst’s Disclosure:I/we have a beneficial long position in the shares of ULTY either through stock ownership, options, or other derivatives. I wr ...

Take a Trial Today Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! IBD Videos SPECIAL REPORT: See The Most Trusted Financial Firms By Category Renewable energy and power supplier Bloom Energy (BE) has roared higher since it announced in late July it was partnering with Oracle (ORCL) to supply fuel cell technology for the hyperscaler's AI data centers. Now, the stock just received a price target increase that projects a further ...

Coca-Cola Europacific Partners’ joint venture in the Philippines has started a project to build its biggest plant in the country. The construction of the site in Tarlac City, north of Manila, has started, the venture confirmed. A spokesperson for the Coca-Cola Europacific Aboitiz Philippines (CCEAP) venture said the full build will take ten years but the business expects production to start far sooner. “We expect production to begin in the next one-and-a-half years,” the spokesperson said. “We currently ...

Monte Rosa Therapeutics (GLUE) shares soared 44.1% in the last trading session to close at $6.93. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 5% gain over the past four weeks. This surge in stock price came after the company announced that it entered into a multi-billion-dollar collaboration deal with pharma giant Novartis to develop novel therapies for immune-mediated diseases. Per the deal terms, Novartis will receive an ex ...

According to CoinDesk Data, ether (ETH) traded at $4,506, down 0.5% in the past 24-hour period, as of 12:24 UTC on Sept. 16, slipping slightly in the past 24 hours as traders debate whether this pullback will set up the next rally. Fundstrat's view Mark Newton, Global Head of Technical Strategy at Fundstrat Global Advisors, described the decline as the correction the market missed last week. He does not expect ether to fall below its prior low of $4,233. Instead, he sees possible dips to $4,418 or $4,375 ...